Sanofi SA

Common Name

Sanofi

Country

France

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

82,878

Ticker

SAN

Exchange

EURONEXT

Website

www.sanofi.com

Description

Sanofi is a leading global pharmaceutical company, renowned for its extensive research, development, and distribution of therapeutic solutions. Primarily focusing on patient healthcare, Sanofi operate... Show more

Income Statement Balance Sheet Group Entities

Sanofi's Financial Statements Preview

Below are the financial statements of Sanofi, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?

Learn More

All figures in billions of EUR	2024	2023	2022
Net sales	41.08^a	37.82^a	37.65^a
Other revenues	3.21^a	3.8^a	2.91^a
Cost of sales	-13.21^a	-12.63^a	-11.88^a
Gross profit	31.08^a	28.99^a	28.68^a
Research and development expenses	-7.39^a	-6.51^a	-6.5^a
Selling and general expenses	-9.18^a	-8.93^a	-8.74^a
Other operating income	1.09^a	0.98^a	1.81^a
Other operating expenses	-4.38^a	-3.44^a	-2.52^a
Amortization of intangible assets	-1.75^a	-1.91^a	-1.8^a
Impairment of intangible assets	-0.25^a	-0.9^a	-0.43^a
Fair value remeasurement of contingent consideration	-0.1^a	-0.09^a	0.03^a
Restructuring costs and similar items	-1.4^a	-1.03^a	-1.08^a
Other gains and losses, and litigation	-0.47^a	-0.2^a	-0.14^a
Operating income	7.25^a	6.96^a	10.16^a
Financial expenses	-1.07^a	-1.29^a	-0.43^a
Financial income	0.52^a	0.58^a	0.21^a
Income before tax and investments accounted for using the equity method	6.7^a	6.25^a	9.94^a
Income tax expense	-1.2^a	-1.02^a	-1.91^a
Share of profit/(loss) from investments accounted for using the equity method	0.06^a	-0.14^a	0.06^a
Net income from continuing operations	5.55^a	5.1^a	8.08^a
Net income from discontinued operations	0.06^a	0.34^a	0.4^a
Net income	5.62^a	5.44^a	8.48^a
Net income attributable to non-controlling interests	0.06^a	0.04^a	0.11^a
Net income attributable to equity holders of Sanofi	5.56^a	5.4^a	8.37^a

Download Data

Verified Sources Behind Sanofi’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sanofi’s data sources below and access millions more through our Disclosure Search.

a. Sanofi's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Sanofi SA

Sanofi's Financial Statements Preview

Verified Sources Behind Sanofi’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Virbac SA

Merck & Co Inc

Roche Holding AG

AstraZeneca PLC

Gilead Sciences Inc

Novo Nordisk A/S